Supplemental Figure S2 from Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophag... by Yueying Liu (1635625)

A Family of Binuclear Dysprosium(III) Radical Compounds with Magnetic Relaxation in ON and OFF States by Tian Han (1674109)

“…The adduct ([Dy­(hfac)₃(PyNONIT)]₂[Dy_0.5(hfac)_1.5(H₂O)]₂) (<b>3</b>) consists of two items, the dimer [Dy­(hfac)₃(PyNONIT)]₂ and the monomer [Dy­(hfac)₃(H₂O)₂], where the symmetry of Dy^III ion in Dy₂O₂ decreases to <i>D</i>_2<i>d</i>, showing slow relaxation of the magnetization at lower temperature. …”

Validation of mitochondrial fission/fusion genes in heads of Ssdp overexpressing flies. by Safa Salim (9186786)

Physiological Markers of Arousal Change with Psychological Treatment for Insomnia: A Preliminary Investigation by Christopher B. Miller (838716)

“…</p><p>Results</p><p>Eight (73%) patients out of 11 consented completed therapy and showed a decrease in insomnia severity pre-to-post treatment (mean (SD): 18.1 (2.8) versus 8.4 (4.8); <i>p</i> = .001). …”

Supplementary Material for: MNSFβ Promotes the Proliferation and Migration of Human Extravillous Trophoblast Cells and the Villus Expression Level of MNSFβ Is Decreased in Recurren... by Wang N. (3112722)

Deletion of <i>iscR</i> decreases <i>K. pneumoniae</i> Δ<i>fur</i> siderophore production assessed using CAS assay. by Chien-Chen Wu (281137)

Data Sheet 1_Evaluating the efficacy of different doses of tocilizumab in treating critically ill COVID–19 patients: a single–center retrospective cohort study.docx by Jie Gao (10266)

Loss of pathogenicity of the <i>abpacc</i> mutant and decreased virulence of Δ<i>abvf8</i> compared to wild-type <i>Alternaria brassicicola</i>. by Yangrae Cho (816)

A fitted regression model that shows the relationship between distillation time (DT) and the concentration (%) of (A) β-caryophyllene, (B) maaliol, (C) germacrene D-4-ol, (D) spath... by Valtcho D. Zheljazkov (627617)

The data of meta-analysis. by Fei Lin (156666)

“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”

Quality assessment for risk of bias for studies. by Fei Lin (156666)

“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”

Effect of tirzepatide vs placebo on body weight. by Fei Lin (156666)

“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”

The results of safety in meta-analysis. by Fei Lin (156666)

“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”

Graphs of risk of bias for studies. by Fei Lin (156666)

“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”

General baseline of included studies. by Fei Lin (156666)

“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”

Splenic DCs of the oxATP recipients have decreased ability to produce IL-23 and IL-6 and were poor stimulators for Th17 autoreactive T cells. by Ronglan Zhao (658986)

Genetic context and molecular phylogenetic analysis of SrpM. by Nicolas Carraro (650366)

<i>Rfx4</i>^-/- embryos at E12.5 and E14.5 exhibit holoprosencephaly. by Ping Xu (122619)

“…<p>Note the complete absence of the developing cerebral hemispheres (CH) in the KO embryo seen in A-C. There was a striking decrease in size of all regions of the brain, but especially the developing midbrain in (D). …”

Values for the calculation of the time-dependent drug concentrations in the system based on observed data found and derived from a variety of sources. by J. Roadnight Sheehan (20141887)

Activity coupling between V2 and the CPu. by Anett J. Nagy (5447606)

“…<p>(A) Experimental schematics showing the simultaneous recording of the LFPs and SUA in both the V2 and the dorsomedial CPu. …”